| Patient | Michelangelo Buonarroti |
|---|---|
| Date of birth | 1941-03-06 |
| Identifiers | MRN HR-RE002-SYN; SSN (made up) 000-02-7781 |
| Document date | 2026-10-19 |
| Author | Serena Castellano, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Hand osteoarthritis and gout review at about seven months. [S]
Mr. Buonarroti returns about seven months after his first visit and five weeks after his wellness visit. His hand pain stays about 3 of 10. He carves three to four hours most mornings with the splint and padded tools and writes his own letters again, if slowly. He takes acetaminophen 1 g on most days and the gel once or twice a day. He has had no gout flare, no urinary symptoms, and no falls. His DXA is booked for next week. [S]
| Element | Detail |
|---|---|
| Pain | About 3 of 10 |
| Function | Carving three to four hours most mornings; writes his own letters |
| Analgesics | Acetaminophen about 1 g a day; gel once or twice a day; no oral NSAIDs |
| Gout and stones | No flare or stone |
| Falls | None |
| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Mild left thumb-base ache after long sessions; no swollen joints or foot pain |
| Genitourinary | Negative | No flank pain, blood in the urine, or straining |
| Gastrointestinal | Negative | No indigestion or dark stools |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 200 mg oral tablet (over the counter), two tablets by mouth three times daily | Two tablets by mouth three times daily | Oral route | 2025-12-01 to 2026-03-16 | stopped | S |
| Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily | Two tablets by mouth daily | Oral route | 2018-06-04 | active | S |
| Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand | Apply 2 g to the affected hand joints four times daily | Topical route | 2026-03-16 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day | Two tablets up to three times daily as needed; maximum 6 tablets a day | Oral route | 2026-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-19 | Body height | 168 | cm | S |
| 2026-10-19 | Body weight | 61.6 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 70 | /min | S |
| 2026-10-19 | Respiratory rate | 16 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-19 | Urate [Mass/volume] in Serum or Plasma | 5.2 | mg/dL | 3.5-7.2 mg/dL | Normal | S |
| 2026-10-19 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-10-19 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-10-19 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-10-19 | Urea nitrogen [Mass/volume] in Serum or Plasma | 19 | mg/dL | 8-23 mg/dL | Normal | S |
| 2026-10-19 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-10-19 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-10-19 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-10-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 17 | U/L | 7-55 U/L | Normal | S |
| 2026-10-19 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 2026-10-19 | PROMIS upper extremity version 2.0 T-score | 43 | {T-score} | S | ||
| 2026-10-19 | Grip strength Hand - left Dynamometer | 18 | kg | S | ||
| 2026-10-19 | Grip strength Hand - right Dynamometer | 23 | kg | S |
Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Left hand | Thumb-base squaring with slight tenderness; no synovitis; thumb abduction a little better than in the spring |
| Right hand | Heberden nodes; no synovitis |
| Feet | No tophi or swelling |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary osteoarthritis of the left hand, worst at the thumb base (first carpometacarpal joint, Eaton stage III), with thumb metacarpophalangeal and interphalangeal and index metacarpophalangeal and proximal interphalangeal involvement; non-erosive | active | confirmed | M19.042 | S — Synthetic modern diagnosis confirmed by examination and radiographs. The joint pattern echoes the retrospective portrait-based interpretation (R, possible), which remains a hypothesis about the historical person; his documented difficulty writing is D. |
| Primary osteoarthritis of the right hand, mild, with Heberden nodes of the index and middle fingers | active | confirmed | M19.041 | S — Synthetic modern diagnosis; the portraits studied show only the left hand. |
| Chronic gout without tophi, in remission on allopurinol with serum urate at target | active | confirmed | M1A.9XX0 | S — Synthetic modern diagnosis, crystal-proven years ago in the synthetic history. Gout in the historical person is a retrospective reading of period language (R, possible). |
| History of urinary stones, passed spontaneously years ago; stone-free on fluids and allopurinol | active | confirmed | Z87.442 | S — Synthetic modern entry linked to the urinary calculus documented in his own letters (D); the composition of his historical stones is not known. |
| Laceration of the left index finger from a slipped chisel, 2.5 cm, without tendon, nerve, or nail injury; repaired and healed | resolved | confirmed | S61.211A | S — Synthetic injury at an unscheduled visit; weak pinch grip from thumb-base osteoarthritis let the chisel slip. It does not echo a documented injury. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Hand pain, 0 to 10 numeric rating | Each clinical encounter; after each therapeutic trial | Completed today | 3 of 10 |
| Survey | Validated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code) | Each clinical encounter | Completed today | T-score 43 (population mean 50; higher is better) |
| Examination | Grip strength by dynamometer | Each clinical encounter in this plan | Completed today | Left 18 kg, right 23 kg |
| Examination | Joint examination | Each clinical encounter | Completed today | No synovitis; slight thumb-base tenderness |
| Laboratory | ALT on regular acetaminophen | Periodically, especially near 3 g a day | Completed today | 17 U/L |
| Laboratory | Serum urate | Every 6 months at target | Completed today | 5.2 mg/dL: at target |
| Laboratory | Creatinine and eGFR for allopurinol dosing and analgesic safety | Every 6 to 12 months | Completed today | Creatinine 1.00 mg/dL, eGFR 74; potassium 4.4 mmol/L |
| Medication safety | Analgesic review: no oral NSAIDs; acetaminophen dose | Each clinical encounter | Completed today | No ibuprofen; acetaminophen about 1 g a day |
| Imaging | Hand radiographs | Not for routine follow-up | Not indicated | Clinical improvement; no repeat imaging |
| Survey | Mood, sleep, and coping screen | Periodically | Up to date | PHQ-2 score 0 at the September wellness visit |
| Self-management | Exercise, joint protection, and splint use | Each clinical encounter | Completed today | Daily exercises; splint for carving |
| Self-management | Gait, balance, and falls | Ongoing | Up to date | No falls; Timed Up and Go 11 seconds in September; DXA booked next week |
| Self-management | Fluid intake for stone prevention | Each clinical encounter | Completed today | About 2 L of water a day |
Goal progress:
Guideline basis: 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Osteoporosis to Prevent Fractures: Screening (2025)
Follow-up: DXA next week, with a call about the result. Hand and gout review in six months with serum urate. [S]